bioRxivBiophysics
Temporally feathered intensity modulated radiation therapy: a planning technique to reduce normal tissue toxicity
J. C. L. Alfonso, S. Parsai, N. Joshi, A. Godley, C. Shah, S. A. Koyfman, J. J. Caudell, C. D. Fuller, H. Enderling, J. Scott
Abstract
PurposeIntensity modulated radiation therapy (IMRT) has allowed optimization of three-dimensional spatial radiation dose distributions permitting target coverage while reducing normal tissue toxicity. However, radiation-induced normal tissue toxicity is a major contributor to patients quality of life and often a dose-limiting factor in the definitive treatment of cancer with radiation therapy. We propose the next logical step in the evolution of IMRT using canonical radiobiological principles, optimizing the temporal dimension through which radiation therapy is delivered to further reduce radiation-induced toxicity by increased time for normal tissue recovery. We term this novel treatment planning strategy \"temporally feathered radiotherapy\" (TFRT).\n\nMethodsTFRT plans were generated as a composite of five simulated treatment plans each with altered constraints on particular hypothetical organs at risk (OARs) to be delivered sequentially. For each of these TFRT plans, OARs chosen for feathering receive higher doses while the remaining OARs receive lower doses than the standard fractional dose delivered in a conventional fractionated IMRT plan. Each TFRT plan is delivered a specific weekday, which in effect leads to a higher dose once weekly followed by four lower fractional doses to each temporally feathered OAR. We compared normal tissue toxicity between TFRT and conventional fractionated IMRT plans by using a dynamical mathematical model to describe radiation-induced tissue damage and repair over time.\n\nResultsModel-based simulations of TFRT demonstrated potential for reduced normal tissue toxicity compared to conventionally planned IMRT. The sequencing of high and low fractional doses delivered to OARs by TFRT plans suggested increased normal tissue recovery, and hence less overall radiation-induced toxicity, despite higher total doses delivered to OARs compared to conventional fractionated IMRT plans. The magnitude of toxicity reduction by TFRT planning was found to depend on the corresponding standard fractional dose of IMRT and organ-specific recovery rate of sublethal radiation-induced damage.\n\nConclusionsTFRT is a novel technique for treatment planning and optimization of therapeutic radiotherapy that considers the non-linear aspects of tissue repair to optimize toxicity profiles. Model-based simulations of TFRT to carefully conceptualized clinical cases have demonstrated potential for normal tissue toxicity reduction in a previously described dynamical model of normal tissue complication probability (NTCP).
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Laser-driven VHEE pulsed fast fractionation (PFF): second-scale inter-pulse timing can modulate normal tissue toxicity in vivo
Camilla Giaccaglia, Émilie Bayart, … A. Flacco·bioRxiv·Sep 12, 2026
- FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone.
Ioannis I. Verginadis, Anastasia P. Velalopoulou, … Theresa M. Busch·Radiotherapy and OncologyPeer-reviewed·Jan 27, 2025
- Decrease in dose per fraction impairs the FLASH sparing effect in murine intestine model
Anouk Sesink, R. Geyer, … Veljko Grilj·Radiotherapy and OncologyPeer-reviewed·Nov 3, 2025
- Radio-Immune Response Modelling for Spatially Fractionated Radiotherapy
Y.-B. Cho, N. Yoon, … S. G. Jacob·bioRxiv·Apr 28, 2023
- Targeting C5aR1 Increases the Therapeutic Window of Radiotherapy
M. M. Olcina, S. Melemenidis, … A. J. Giaccia·bioRxiv·Oct 27, 2020
- Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters - A preclinical study in a Fisher 344 rat model
J. N. Rivera, T. M. Kierski, … S. Chang·bioRxiv·Jan 30, 2020